Assessment and management of pain, with particular emphasis on central neuropathic pain, in moderate to severe dementia

Drugs and Aging

Volumn 29, Issue 9, 2012, Pages 701-706

  Scherder, Erik J A ^a   Plooij, Bart ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PARACETAMOL; PREGABALIN; ANTICONVULSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SHORT ACTING DRUG; SUFENTANIL;

AGITATION; ALLODYNIA; ANALGESIA; ANXIETY; ARTICLE; ATAXIA; BABINSKI REFLEX; CENTRAL NEUROPATHIC PAIN; COGNITION; COGNITIVE DEFECT; COLOR PAIN ASSESSMENT SCALE; CONFUSION; DELUSION; DEMENTIA; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; EVENING DOSAGE; FACES PAIN SCALE; FUNCTIONAL PAIN SCALE; GLOBAL PAIN ASSESSMENT SCALE; HEART ARRHYTHMIA; HEART RATE; HUMAN; HYPERTENSION; IMMOBILIZATION; MINI MENTAL STATE EXAMINATION; NEUROPATHIC PAIN; NUMERIC RATING SCALE; PAIN ASSESSMENT; PRESENT PAIN INTENSITY; PRIORITY JOURNAL; RATING SCALE; SELF REPORT; SPASTICITY; STROKE PATIENT; TEMPERATURE SENSE; TENDON REFLEX; TOUCH; TRANSCUTANEOUS NERVE STIMULATION; VERBAL DESCRIPTOR SCALE; VERBAL NUMERIC RATING SCALE; VERBAL RATING SCALE; VIBRATION SENSE; VISUAL ANALOG SCALE; WHITE MATTER LESION; CHRONIC PAIN; DISRUPTIVE BEHAVIOR; DIZZINESS; DROWSINESS; DRUG DOSE REDUCTION; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LOADING DRUG DOSE; LOW DRUG DOSE; MENTAL DETERIORATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PAIN; PAIN THERMOMETER; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SOMATOSENSORY SYSTEM; VISUAL DISORDER; WANDERING BEHAVIOR; WEIGHT GAIN;

DEMENTIA; HUMANS; NEURALGIA; PAIN MANAGEMENT; PAIN MEASUREMENT;

EID: 84872557414     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-012-0001-8     Document Type: Article

References (47)

1. Brown ST, Kirkpatrick MK, Swanson MS, et al. Pain experience of the elderly. Pain Manag Nurs. 2011;12(4):190-6.
2. Woolf AD, Vos T, March L. How to measure the impact of musculoskeletal conditions. Best Pract Res Clin Rheumatol. 2010;24(6):723-32.
3. Smith AK, Stijacic Cenzer I, Knight SJ, et al. The epidemiology of pain during the last two years of life. Ann Intern Med. 2010;153(9):563-9.
4. Baan MAG, Mesa AA, Adriaens-van der Steen AL, et al. Survey on the prevalence of pain in Dutch district nursing care. J Palliat Med. 2011;14(6):696-9.
5. Husebo BS, Strand LI, Moe-Nilssen R, et al. Pain in older persons with severe dementia: psychometric properties of the Mobilization-Observation- Behaviour-Intensity-Dementia (MOBID-2) Pain Scale in a clinical setting. Scand J Caring Sci. 2010;24(2):380-91.
6. Ferrell BA, Ferrell BR, Rivera L. Pain in cognitively impaired nursing home patients. J Pain Symptom Manag. 1995;10(8):591-8.
7. Black BS, Finucane T, Baker A, et al. Health problems and correlates of pain in nursing home residents with advanced dementia. Alzheimer Dis Assoc Disord. 2006;20(4):283-90. (Pubitemid 44900943)
8. Siniscalchi A, Gallelli L, De Sarro G, et al. Antiepileptic drugs for central post-stroke pain management. Pharmacol Res. 2012;65:171-5.
9. Morrison RS, Siu AL. A comparison of pain and its treatment in advanced dementia and cognitively intact patients with hip fracture. J Pain Symptom Manag. 2000;19(4):240-8. (Pubitemid 30224690)
10. Plooij B, van der Spek K, Scherder EJ. Pain medication and global cognitive functioning in dementia patients with painful conditions. Drugs Aging. 2012;29(5):377-84.
11. Haanpää M, Hietaharju A. Central neuropathic pain. In: Kopf A, Patel NB, editors. Guide to pain management in low-resource settings. Seattle: IASP; 2010. p. 189-95.
12. Hong JH, Bai DS, Jeong JY, et al. Injury of the spino-thalamo-cortical pathway is necessary for central post-stroke pain. Eur Neurol. 2010;64(3):163-8.
13. Scherder EJA, Sergeant JA, Swaab DF. Pain processing in dementia and its relation to neuropathology. Lancet Neurol. 2003;2(11):677-86. (Pubitemid 37311321)
14. Tomimoto H. Subcortical vascular dementia. Neurosci Res. 2011;71(3):193-9.
15. Scherder EJ, Slaets J, Deijen JB, et al. Pain assessment in patients with possible vascular dementia. Psychiatry. 2003;66(2):133-45. (Pubitemid 36869715)
16. Achterberg WP, Scherder E, Pot AM, et al. Cardiovascular risk factors in cognitively impaired nursing home patients: a relationship with pain? Eur J Pain. 2007;11(6):707-10. (Pubitemid 46818061)
17. Jones KR, Vojir CP, Hutt E, et al. Determining mild, moderate, and severe pain equivalency across pain intensity tools in nursing home residents. J Rehabil Res Dev. 2007;44(2):305-14. (Pubitemid 46890050)
18. Cohen-Mansfield J. The relationship between different pain assessments in dementia. Alzheimer Dis Assoc Disord. 2008;22(1):86-93. (Pubitemid 351651403)
19. Folstein MF, Folstein FE, McHugh PR. Mini-mental state. J Psychiatr Res. 1975;12:189-98.
20. Pautex S, Michon A, Guedira M, et al. Pain in severe dementia: self-assessment or observational scales? J Am Geriatr Soc. 2006;54(7):1040-5. (Pubitemid 43992539)
21. Herr KA, Spratt K, Mobily PR, et al. Pain intensity assessment in older adults: use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults. Clin J Pain. 2004;20(4):207-19. (Pubitemid 38802807)
22. Herr K, Bursch H, Ersek M, et al. Use of pain-behavioral assessment tools in the nursing home expert consensus recommendations for practice. J Gerontol Nurs. 2010;36(3):18-31.
23. Zwakhalen SMG, Hamers JPH, Huda Huijer Abu-Saad H, et al. Pain in elderly people with severe dementia: a systematic review of behavioural pain assessment tools. BMC Geriatr. 2006;6:3. (Pubitemid 43373415)
24. Ersek M, Herr K, Neradilek MB, et al. Comparing the psychometric properties of the checklist of nonverbal pain behaviors (CNPI) and the pain assessment in advanced dementia (PAIN-AD) instruments. Pain Med. 2010;11(3):395-404.
25. City of Hope Pain and Palliative Care Resource Center. State of the art review of tools for assessment of pain in nonverbal older adults (online). http://prc.coh.org/PAIN-NOA.htm (Accessed 2012 Jun 22).
26. Herr K, Coyne PJ, Key T, et al. Pain assessment in the nonverbal patient: position statement with clinical practice recommendations. Pain Manag Nurs. 2006;7(2):44-52. (Pubitemid 43758001)
27. Horgas AL, Elliott AF, Marsiske M. Pain assessment in persons with dementia: relationship between self-report and behavioral observation. J Am Geriatr Soc. 2009;57(1):126-32.
28. Cipher DJ, Clifford PA, Roper KD. Behavioral manifestations of pain in the demented elderly. J Am Med Dir Assoc. 2006;7(6):355-65. (Pubitemid 44054905)
29. Plooij B, Swaab D, Scherder E. Autonomic responses to pain in aging and dementia. Rev Neurosci. 2011;22(5):583-9.
30. Porter FL, Malhotra KM, Wolf CM, et al. Dementia and response to pain in the elderly. Pain. 1996;68(2-3):413-21. (Pubitemid 27025901)
31. Benedetti F, Arduino C, Vighetti S, et al. Pain reactivity in Alzheimer patients with different degrees of cognitive impairment and brain electrical activity deterioration. Pain. 2004;111(1-2):22-9. (Pubitemid 39141003)
32. Rainero I, Vighetti S, Bergamasco B, et al. Autonomic responses and pain perception in Alzheimer's disease. Eur J Pain. 2000;4(3):267-74.
33. Ram CV. Beta-blockers in hypertension. Am J Cardiol. 2010;106(12):1819- 25.
34. Basile J. The role of existing and newer calcium channel blockers in the treatment of hypertension. J Clin Hypertens. 2004;6(11):621-31.
35. Lovick TA. Pro-nociceptive action of cholecystokinin in the periaqueductal grey: a role in neuropathic and anxiety-induced hyperalgesic states. Neurosci Biobehav Rev. 2008;32(4):852-62.
36. Scherder E, Oosterman J, Swaab D, et al. Recent developments in pain in dementia. BMJ. 2005;330(7489):461-6.
37. Elseviers MM, Vander Stichele RR, Van Bortel L. Drug utilization in Belgian nursing homes: impact of residents' and institutional characteristics. Pharmacoepidemiol Drug Saf. 2010;19(10):1041-8.
38. Haasum Y, Fastbom J, Fratiglioni L, et al. Pain treatment in elderly persons with and without dementia: a population-based study of institutionalized and home-dwelling elderly. Drugs Aging. 2011;28(4):283-93.
39. Passmore MJ. Sublingual sufentanil for incident pain and dementia-related response agitation. Int Psychogeriatr. 2011;23:844-6.
40. Perucca E, Berlowitz D, Birnbaum A, et al. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res. 2006;68(Suppl. 1):49-63. (Pubitemid 43143413)
41. Jickling G, Heino A, Ahmed SN. Acetaminophen toxicity with concomitant use of carbamazepine. Epileptic Disord. 2009;11(4):329-32.
42. Murphy EJ. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care. 2005;33(3):311-22. (Pubitemid 40903428)
43. Faught E. Epidemiology and drug treatment of epilepsy in elderly people. Drugs Aging. 1999;15(4):255-69. (Pubitemid 29504949)
44. Zand L, McKian KP, Qian Q. Gabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidity. Am J Med. 2010;123(4):367-73.
45. Pregabalin: new drug. Very similar to gabapentin. Prescire Int. 2005;14(80):203-6.
46. Knegtering H, Eijck M, Huijsman A. Effects of antidepressants on cognitive functioning of elderly patients: a review. Drugs Aging. 1994;5(3):192-9. (Pubitemid 2132660)
47. Mendez M, Lim G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging. 2003;20(11):791-803. (Pubitemid 37159597)